Finding treatments for dry age-related macular degeneration requires a large-scale, collaborative, systems biology approach.
Dry AMD, which currently has no treatment options, is a leading cause of blindness in people aged 65 years and older.
A report published in Nature Communications proposed researchers use a broad approach, integrating data available from clinical registries and biology to develop models and possibly treatments for dry AMD, a press release from the National Eye Institute said.
“This approach would integrate basic, genomic, preclinical, medical, pharmacological and
Uncategorized